Search

Displaying results 9761 - 9770 of 10000 in total
  1. Drug

    Decoquinate

    go.drugbank.com/drugs/DB11394
    ExperimentalVet approved

    Decoquinate is used in veterinary to delay the growth and reproduction of coccidian parasites.

  2. Drug

    BPC-157

    go.drugbank.com/drugs/DB11882
    Investigational

    Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).

  3. Drug

    Letosteine

    go.drugbank.com/drugs/DB08939
    Experimental

    Letosteine is a mucolytic used in the treatment of chronic bronchopneumopathies and related conditions.

  4. Drug

    Nona-arginine

    go.drugbank.com/drugs/DB12648
    Investigational

    Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).

  5. Drug

    Gam-COVID-Vac

    go.drugbank.com/drugs/DB15848
    Investigational

    June 2020, and were completed in early August 2020. … The vaccine is offered in both a frozen (Gam-COVID-Vac) and freeze-dried formulation (lyophilizate; Gam-COVID-Vac Lyo).

  6. Drug

    tgAAVCF

    go.drugbank.com/drugs/DB17849
    Investigational

    It is being investigated for the treatment of cystic fibrosis.[A259821, A259826] … tgAAVCF is an adeno-associated virus (AAV) vector encoding the human cystic fibrosis transmembrane conductance regulator protein (CFTR) cDNA.

  7. Drug

    TRTL-729

    go.drugbank.com/drugs/DB33923
    Experimental

    TRTL-729 is a small molecule drug. TRTL-729 is under investigation in clinical trial NCT07811063 (A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729).

  8. Drug

    Fluciclatide

    go.drugbank.com/drugs/DB14842
    Investigational

    The conditions targeted by [18F]Fluciclatide in these studies include high-grade glioma, lung cancer, and kidney neoplasms … Fluciclatide, an investigational radiotracer intended for PET imaging, was under investigation in clinical trials NCT00565721 and NCT01961583 to evaluate its ability to detect tumors and angiogenesis.

  9. Drug

    Palladium Pd-103

    go.drugbank.com/drugs/DB15016
    Experimental

    Palladium Pd-103 is under investigation in clinical trial NCT00247312 (Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial).

  10. Drug

    Snubh-nm-333 F-18

    go.drugbank.com/drugs/DB15457
    Experimental

    Snubh-nm-333 F-18 is under investigation in clinical trial NCT02149017 (Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)).